Literature DB >> 26149460

TERT Polymorphism rs2736100-C Is Associated with EGFR Mutation-Positive Non-Small Cell Lung Cancer.

Rongrong Wei1, Lan Cao2, Hengying Pu3, Hongwei Wang4, Yonglan Zheng4, Xiaomin Niu5, Xiaoling Weng6, Hong Zhang6, Murray Favus4, Lanjun Zhang7, Weihua Jia3, Yixin Zeng3, Christopher I Amos8, Shun Lu5, Hui-Yun Wang3, Yun Liu6, Wanqing Liu1.   

Abstract

PURPOSE: EGF receptor (EGFR) mutation-positive (EGFRmut(+)) non-small cell lung cancer (NSCLC) may be a unique orphan disease. Previous studies suggested that the telomerase reverse transcriptase (TERT) gene polymorphism is associated with demographic and clinical features strongly associated with EGFR mutations, for example, adenocarcinoma histology, never-smoking history, and female gender. We aim to test the association between TERT polymorphism and EGFRmut(+) NSCLC. EXPERIMENTAL
DESIGN: We conducted a genetic association study in Chinese patients with NSCLC (n = 714) and healthy controls (n = 2,520), between the rs2736100 polymorphism and EGFRmut(+) NSCLC. We further tested the association between the EGFR mutation status and mean leukocyte telomere length (LTL). The potential function of rs2736100 in lung epithelial cells was also explored.
RESULTS: The rs2736100-C allele was significantly associated with EGFRmut(+) NSCLC [OR, 1.52; 95% confidence interval (CI), 1.28-1.80; P = 1.6 × 10(-6)] but not EGFRmut(-) NSCLC (OR = 1.07, 95% CI, 0.92-1.24, P = 0.4). While patients with NSCLC as a whole have significantly longer LTL than healthy controls (P ≤ 10(-13)), the EGFRmut(+) patients have even longer LTL than EGFRmut(-) patients (P = 0.008). Meanwhile, rs2736100 was significantly associated with TERT mRNA expression in both normal and tumor lung tissues. All results remained significant after controlling for age, gender, smoking status, and histology (P < 0.05 for all tests). Moreover, the rs2736100 DNA sequence has an allele-specific affinity to nuclear proteins extracted from lung epithelial cells, which led to an altered enhancer activity of the sequence in vitro.
CONCLUSIONS: Our study suggests that telomerase and telomere function may be essential for carcinogenesis of EGFRmut(+) NSCLC. Further investigation for the underlying mechanism is warranted. ©2015 American Association for Cancer Research.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 26149460      PMCID: PMC4644673          DOI: 10.1158/1078-0432.CCR-15-0009

Source DB:  PubMed          Journal:  Clin Cancer Res        ISSN: 1078-0432            Impact factor:   12.531


  47 in total

1.  The impact of human EGFR kinase domain mutations on lung tumorigenesis and in vivo sensitivity to EGFR-targeted therapies.

Authors:  Hongbin Ji; Danan Li; Liang Chen; Takeshi Shimamura; Susumu Kobayashi; Kate McNamara; Umar Mahmood; Albert Mitchell; Yangping Sun; Ruqayyah Al-Hashem; Lucian R Chirieac; Robert Padera; Roderick T Bronson; William Kim; Pasi A Jänne; Geoffrey I Shapiro; Daniel Tenen; Bruce E Johnson; Ralph Weissleder; Norman E Sharpless; Kwok-Kin Wong
Journal:  Cancer Cell       Date:  2006-05-25       Impact factor: 31.743

2.  MC1R germline variants confer risk for BRAF-mutant melanoma.

Authors:  Maria Teresa Landi; Jürgen Bauer; Ruth M Pfeiffer; David E Elder; Benjamin Hulley; Paola Minghetti; Donato Calista; Peter A Kanetsky; Daniel Pinkel; Boris C Bastian
Journal:  Science       Date:  2006-06-29       Impact factor: 47.728

3.  A functional common polymorphism in a Sp1 recognition site of the epidermal growth factor receptor gene promoter.

Authors:  Wanqing Liu; Federico Innocenti; Michael H Wu; Apurva A Desai; M Eileen Dolan; Edwin H Cook; Mark J Ratain
Journal:  Cancer Res       Date:  2005-01-01       Impact factor: 12.701

4.  Lung adenocarcinomas induced in mice by mutant EGF receptors found in human lung cancers respond to a tyrosine kinase inhibitor or to down-regulation of the receptors.

Authors:  Katerina Politi; Maureen F Zakowski; Pang-Dian Fan; Emily A Schonfeld; William Pao; Harold E Varmus
Journal:  Genes Dev       Date:  2006-05-16       Impact factor: 11.361

5.  A germline JAK2 SNP is associated with predisposition to the development of JAK2(V617F)-positive myeloproliferative neoplasms.

Authors:  Outi Kilpivaara; Semanti Mukherjee; Alison M Schram; Martha Wadleigh; Ann Mullally; Benjamin L Ebert; Adam Bass; Sachie Marubayashi; Adriana Heguy; Guillermo Garcia-Manero; Hagop Kantarjian; Kenneth Offit; Richard M Stone; D Gary Gilliland; Robert J Klein; Ross L Levine
Journal:  Nat Genet       Date:  2009-03-15       Impact factor: 38.330

6.  Relationship of EGFR mutations, expression, amplification, and polymorphisms to epidermal growth factor receptor inhibitors in the NCI60 cell lines.

Authors:  Wanqing Liu; Xiaolin Wu; Wei Zhang; Raquel C Montenegro; Donna Lee Fackenthal; Jared A Spitz; Lyn Mickley Huff; Federico Innocenti; Soma Das; Edwin H Cook; Nancy J Cox; Susan E Bates; Mark J Ratain
Journal:  Clin Cancer Res       Date:  2007-11-15       Impact factor: 12.531

7.  MC1R variants increase risk of melanomas harboring BRAF mutations.

Authors:  Maria Concetta Fargnoli; Maria Concetia Fargnoli; Kris Pike; Ruth M Pfeiffer; Shirley Tsang; Ester Rozenblum; David J Munroe; Yelena Golubeva; Donato Calista; Stefania Seidenari; Daniela Massi; Paolo Carli; Juergen Bauer; David E Elder; Boris C Bastian; Ketty Peris; Maria T Landi
Journal:  J Invest Dermatol       Date:  2008-03-27       Impact factor: 8.551

8.  Lung cancer susceptibility locus at 5p15.33.

Authors:  James D McKay; Rayjean J Hung; Valerie Gaborieau; Paolo Boffetta; Amelie Chabrier; Graham Byrnes; David Zaridze; Anush Mukeria; Neonilia Szeszenia-Dabrowska; Jolanta Lissowska; Peter Rudnai; Eleonora Fabianova; Dana Mates; Vladimir Bencko; Lenka Foretova; Vladimir Janout; John McLaughlin; Frances Shepherd; Alexandre Montpetit; Steven Narod; Hans E Krokan; Frank Skorpen; Maiken Bratt Elvestad; Lars Vatten; Inger Njølstad; Tomas Axelsson; Chu Chen; Gary Goodman; Matt Barnett; Melissa M Loomis; Jan Lubiñski; Joanna Matyjasik; Marcin Lener; Dorota Oszutowska; John Field; Triantafillos Liloglou; George Xinarianos; Adrian Cassidy; Paolo Vineis; Francoise Clavel-Chapelon; Domenico Palli; Rosario Tumino; Vittorio Krogh; Salvatore Panico; Carlos A González; José Ramón Quirós; Carmen Martínez; Carmen Navarro; Eva Ardanaz; Nerea Larrañaga; Kay Tee Kham; Timothy Key; H Bas Bueno-de-Mesquita; Petra Hm Peeters; Antonia Trichopoulou; Jakob Linseisen; Heiner Boeing; Göran Hallmans; Kim Overvad; Anne Tjønneland; Merethe Kumle; Elio Riboli; Diana Zelenika; Anne Boland; Marc Delepine; Mario Foglio; Doris Lechner; Fumihiko Matsuda; Helene Blanche; Ivo Gut; Simon Heath; Mark Lathrop; Paul Brennan
Journal:  Nat Genet       Date:  2008-11-02       Impact factor: 38.330

9.  Gain at chromosomal region 5p15.33, containing TERT, is the most frequent genetic event in early stages of non-small cell lung cancer.

Authors:  Ji Un Kang; Sun Hoe Koo; Kye Chul Kwon; Jong Woo Park; Jin Man Kim
Journal:  Cancer Genet Cytogenet       Date:  2008-04-01

10.  Oncogenic transformation by inhibitor-sensitive and -resistant EGFR mutants.

Authors:  Heidi Greulich; Tzu-Hsiu Chen; Whei Feng; Pasi A Jänne; James V Alvarez; Mauro Zappaterra; Sara E Bulmer; David A Frank; William C Hahn; William R Sellers; Matthew Meyerson
Journal:  PLoS Med       Date:  2005-10-04       Impact factor: 11.069

View more
  25 in total

1.  Investigation of Leukocyte Telomere Length and Genetic Variants in Chromosome 5p15.33 as Prognostic Markers in Lung Cancer.

Authors:  Linda Kachuri; Jens Helby; Stig Egil Bojesen; David C Christiani; Li Su; Xifeng Wu; Adonina Tardón; Guillermo Fernández-Tardón; John K Field; Michael P Davies; Chu Chen; Gary E Goodman; Frances A Shepherd; Natasha B Leighl; Ming S Tsao; Yonathan Brhane; M Catherine Brown; Kevin Boyd; Daniel Shepshelovich; Lei Sun; Christopher I Amos; Geoffrey Liu; Rayjean J Hung
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2019-07       Impact factor: 4.254

2.  Subtype variation and actionability of telomere length abnormality in lung cancer.

Authors:  Felicia Goh; Ian A Yang; Rayleen V Bowman; Kwun M Fong
Journal:  Transl Lung Cancer Res       Date:  2018-09

3.  Association Analysis of Driver Gene-Related Genetic Variants Identified Novel Lung Cancer Susceptibility Loci with 20,871 Lung Cancer Cases and 15,971 Controls.

Authors:  Yuzhuo Wang; Olga Y Gorlova; Ivan P Gorlov; Meng Zhu; Juncheng Dai; Demetrius Albanes; Stephen Lam; Adonina Tardon; Chu Chen; Gary E Goodman; Stig E Bojesen; Maria Teresa Landi; Mattias Johansson; Angela Risch; Heunz-Erich Wichmann; Heike Bickeboller; David C Christiani; Gad Rennert; Susanne M Arnold; Paul Brennan; John K Field; Sanjay Shete; Loïc Le Marchand; Olle Melander; Hans Brunnstrom; Geoffrey Liu; Rayjean J Hung; Angeline S Andrew; Lambertus A Kiemeney; Shanbeh Zienolddiny; Kjell Grankvist; Mikael Johansson; Neil E Caporaso; Penella J Woll; Philip Lazarus; Matthew B Schabath; Melinda C Aldrich; Victoria L Stevens; Hongxia Ma; Guangfu Jin; Zhibin Hu; Christopher I Amos; Hongbing Shen
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2020-04-10       Impact factor: 4.254

4.  Case-Control Study on Impact of the Telomerase Reverse Transcriptase Gene Polymorphism and Additional Single Nucleotide Polymorphism (SNP)- SNP Interaction on Non-Small Cell Lung Cancers Risk in Chinese Han Population.

Authors:  Yan-Li Xing; Feng Liu; Jian-Feng Li; Jian-Cong Lin; Guo-Dong Zhu; Ming Li; Chang-Ran Zhang; Yuan-Yuan Niu
Journal:  J Clin Lab Anal       Date:  2016-05-07       Impact factor: 2.352

5.  Identification of rs2736099 as a novel cis-regulatory variation for TERT and implications for tumorigenesis and cell proliferation.

Authors:  Qiang Shi; Xin-Xin Zhang; Xiao-Qian Shi; Ying Chen; Chang Sun
Journal:  J Cancer Res Clin Oncol       Date:  2022-09-21       Impact factor: 4.322

6.  Combining Telomerase Reverse Transcriptase Genetic Variant rs2736100 with Epidemiologic Factors in the Prediction of Lung Cancer Susceptibility.

Authors:  Xu Wang; Kewei Ma; Lumei Chi; Jiuwei Cui; Lina Jin; Ji-Fan Hu; Wei Li
Journal:  J Cancer       Date:  2016-04-28       Impact factor: 4.207

7.  TERT Gene rs2736100 and rs2736098 Polymorphisms are Associated with Increased Cancer Risk: A Meta-Analysis.

Authors:  Xinyu Zhang; Yan Chen; Donglin Yan; Jing Han; Longbiao Zhu
Journal:  Biochem Genet       Date:  2021-06-28       Impact factor: 1.890

8.  Association of variations in HLA class II and other loci with susceptibility to EGFR-mutated lung adenocarcinoma.

Authors:  Kouya Shiraishi; Yukinori Okada; Atsushi Takahashi; Yoichiro Kamatani; Yukihide Momozawa; Kyota Ashikawa; Hideo Kunitoh; Shingo Matsumoto; Atsushi Takano; Kimihiro Shimizu; Akiteru Goto; Koji Tsuta; Shun-Ichi Watanabe; Yuichiro Ohe; Yukio Watanabe; Yasushi Goto; Hiroshi Nokihara; Koh Furuta; Akihiko Yoshida; Koichi Goto; Tomoyuki Hishida; Masahiro Tsuboi; Katsuya Tsuchihara; Yohei Miyagi; Haruhiko Nakayama; Tomoyuki Yokose; Kazumi Tanaka; Toshiteru Nagashima; Yoichi Ohtaki; Daichi Maeda; Kazuhiro Imai; Yoshihiro Minamiya; Hiromi Sakamoto; Akira Saito; Yoko Shimada; Kuniko Sunami; Motonobu Saito; Johji Inazawa; Yusuke Nakamura; Teruhiko Yoshida; Jun Yokota; Fumihiko Matsuda; Keitaro Matsuo; Yataro Daigo; Michiaki Kubo; Takashi Kohno
Journal:  Nat Commun       Date:  2016-08-09       Impact factor: 14.919

9.  TERT rs2736100 genotypes are associated with differential risk of myeloproliferative neoplasms in Swedish and Chinese male patient populations.

Authors:  Jenny Dahlström; Tiantian Liu; Xiaotian Yuan; Leonie Saft; Mehran Ghaderi; Ya Bin Wei; Catharina Lavebratt; Ping Li; Chengyun Zheng; Magnus Björkholm; Dawei Xu
Journal:  Ann Hematol       Date:  2016-08-25       Impact factor: 3.673

Review 10.  Gene aberrations for precision medicine against lung adenocarcinoma.

Authors:  Motonobu Saito; Kouya Shiraishi; Hideo Kunitoh; Seiichi Takenoshita; Jun Yokota; Takashi Kohno
Journal:  Cancer Sci       Date:  2016-05-25       Impact factor: 6.716

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.